Ligand validation:4RAK

BU1: 1,4-BUTANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4RAK_BU1_A_501	29%	80%	0.183	0.847	0.35	0.42	-	-	0	0	100%	1
4RAK_BU1_B_501	25%	75%	0.219	0.862	0.3	0.57	-	-	0	0	100%	1
4RAK_BU1_A_502	0%	87%	0.891	0.658	0.38	0.26	-	-	3	0	100%	1
5JY3_BU1_D_502	52%	54%	0.19	0.952	0.3	1.31	-	-	5	0	100%	1
4OP4_BU1_B_305	98%	87%	0.05	0.984	0.24	0.39	-	-	0	0	100%	1
4S27_BU1_A_707	97%	96%	0.057	0.983	0.13	0.21	-	-	0	0	100%	0.53
3CED_BU1_A_402	94%	77%	0.071	0.978	0.22	0.6	-	-	0	0	100%	1
4S28_BU1_A_706	94%	96%	0.077	0.982	0.19	0.14	-	-	0	0	100%	0.52
4S29_BU1_A_703	91%	93%	0.084	0.98	0.17	0.27	-	-	0	0	100%	0.5

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.